Your browser doesn't support javascript.
loading
Circulating Tumor Cells (CTC) Are Associated with Defects in Adaptive Immunity in Patients with Inflammatory Breast Cancer.
Mego, M; Gao, H; Cohen, E N; Anfossi, S; Giordano, A; Sanda, T; Fouad, T M; De Giorgi, U; Giuliano, M; Woodward, W A; Alvarez, R H; Valero, V; Ueno, N T; Hortobagyi, G N; Cristofanilli, M; Reuben, J M.
Afiliação
  • Mego M; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 5. Currently at 2nd Department of Oncology, Faculty of Medicine, Comenius University and National Cancer Institute, Bratislava, Slovakia;
  • Gao H; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Cohen EN; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Anfossi S; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Giordano A; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Sanda T; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Fouad TM; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • De Giorgi U; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 6. Currently at Medical Oncology, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) - IRCCS, Meldola (FC), Italy;
  • Giuliano M; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 7. Currently at Department of Clinical Medicine and Surgery, University Federico II, Naples. Italy;
  • Woodward WA; 3. Department of Radiation Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Alvarez RH; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 4. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 8. Currently at Cancer Treatment Centers of
  • Valero V; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 4. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Ueno NT; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 4. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Hortobagyi GN; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
  • Cristofanilli M; 2. Department of Breast Medical Oncology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 9. Currently at Thomas Jefferson University-Kimmel Cancer Center, Philadelphia, PA, USA.
  • Reuben JM; 1. Department of Hematopathology, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;; 4. Morgan Welch Inflammatory Breast Cancer Research Program and Clinic, The University of Texas, MD Anderson Cancer Center, Houston, TX, USA;
J Cancer ; 7(9): 1095-104, 2016.
Article em En | MEDLINE | ID: mdl-27326253
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Ano de publicação: 2016 Tipo de documento: Article